The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Washington sent Congress a long-awaited supplemental funding package on Wednesday aimed at covering Iran war…
Terrorists Target Government School in South Waziristan Lower Unidentified terrorists detonated explosives at a government…
French TV host France Pierron has apologized for her comments criticizing soccer star Jérémy Doku's…
Brent crude futures fell over $3 to their lowest level since before the Iran war…
Iran Conflict Pushes Prices to Three-Year High The ongoing conflict with Iran has pushed consumer…
Diplomatic bodies overseeing the International Criminal Court (ICC) have determined that Prosecutor Karim Khan had…
This website uses cookies.
